LCH-7749944 - ≥98% , CAS No.796888-12-5

CAS: 796888-12-5 Cat. No.: L420058 Fórmula: C20H22N4O2 Peso molecular: 350.41
Disponible para pedir
CALIDAD & PUREZA ≥98%
Storage
Room temperature
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
10mg
L420058-10mg
5 Disponible
—

118,90US$

178,90US$
Guardar 60,00 US$ (33.54%)
25mg
L420058-25mg
5 Disponible
—

165,90US$

248,90US$
Guardar 83,00 US$ (33.35%)
50mg
L420058-50mg
4 Disponible
—

230,90US$

346,90US$
Guardar 116,00 US$ (33.44%)
100mg
L420058-100mg
3 Disponible
—

415,90US$

623,90US$
Guardar 208,00 US$ (33.34%)
250mg
L420058-250mg
4 Disponible
—

909,90US$

1.364,90US$
Guardar 455,00 US$ (33.34%)
Enter a quantity for the sizes you want to add.

Especificaciones

Especificaciones y pureza
≥98%
Condiciones de almacenamiento de almacenamiento
Room temperature
Tipo de acción
INHIBITOR
Pureza
≥98%
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488194125
Sonrisas canónicas
COC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)NCC4CCCO4
IUPAC Name
2-N-(3-methoxyphenyl)-4-N-(oxolan-2-ylmethyl)quinazoline-2,4-diamine
InChIKey
FBWZAFQEOKNGQL-UHFFFAOYSA-N
INCHI
1S/C20H22N4O2/c1-25-15-7-4-6-14(12-15)22-20-23-18-10-3-2-9-17(18)19(24-20)21-13-16-8-5-11-26-16/h2-4,6-7,9-10,12,16H,5,8,11,13H2,1H3,(H2,21,22,23,24)
Isómeros SMILES
COC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)NCC4CCCO4
Peso molecular
350.41
Reaxy-Rn
29787985
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=29787985&ln=

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClaseDiazanaphthalenes
SubclassBenzodiazines
Intermediate Tree Nodes Quinazolines
Direct ParentQuinazolinamines
Alternative Parents Methoxyanilines  Phenoxy compounds  Methoxybenzenes  Anisoles  Secondary alkylarylamines  Aminopyrimidines and derivatives  Alkyl aryl ethers  Imidolactams  Tetrahydrofurans  Heteroaromatic compounds  Oxacyclic compounds  Dialkyl ethers  Azacyclic compounds  Organopnictogen compounds  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Quinazolinamine - Methoxyaniline - Phenoxy compound - Anisole - Phenol ether - Methoxybenzene - Aniline or substituted anilines - Alkyl aryl ether - Aminopyrimidine - Secondary aliphatic/aromatic amine - Monocyclic benzene moiety - Pyrimidine - Imidolactam - Benzenoid - Heteroaromatic compound - Tetrahydrofuran - Dialkyl ether - Ether - Oxacycle - Azacycle - Secondary amine - Amine - Organic nitrogen compound - Hydrocarbon derivative - Organonitrogen compound - Organooxygen compound - Organic oxygen compound - Organopnictogen compound - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
PAK4 Tchem Serine/threonine-protein kinase PAK 4 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PAK1 Tchem Serine/threonine-protein kinase PAK 1 (2601 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeFechaArticulo
J22181130J22181130Certificate of AnalysisAug 15, 2025 L420058
J22181129J22181129Certificate of AnalysisAug 15, 2025 L420058
J22181128J22181128Certificate of AnalysisAug 15, 2025 L420058
J22181127J22181127Certificate of AnalysisAug 15, 2025 L420058
J22181126J22181126Certificate of AnalysisAug 15, 2025 L420058
C2503388C2503388Certificate of AnalysisJul 28, 2022 L420058
Propiedades químicas y físicas
Peso molecular350.400 g/mol
XLogP34.100
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass350.174 Da
Monoisotopic Mass350.174 Da
Topological Polar Surface Area68.300 Ų
Heavy Atom Count26
Formal Charge0
Complexity438.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

Validated application protocols are not provided for this listing.

  • Item-specific facts (from Product Data):

    • Tested applications and recommended conditions: Not specified for this item; refer to CoA/Spec Sheet.
  • General example workflow for screening use (not item-specific):

    • Prepare a 10 mM stock in anhydrous DMSO.
    • Create a serial dilution (e.g., 1:3 or 1:2) across a 384-well source plate using acoustic or tip-based dispensing.
    • Transfer to assay plate to achieve final concentrations spanning the desired dose–response range, matching final DMSO (e.g., 0.1% v/v) across all wells including controls.
    • Incubate per assay SOP; read out via the relevant detection modality (fluorescence, luminescence, absorbance, label-free), monitoring for interference.
    • Analyze with a four-parameter logistic model; flag atypical curves for follow-up and orthogonal confirmation.
  • Documentation: Record batch/lot, preparation date, solvent, and final concentration; attach CoA and SDS to the assay record.

Biological Roles

This product is a synthetic small molecule provided for research use; no endogenous biological role is specified.

  • Item-specific facts (from Product Data):

    • Biological/target information: Not specified for this item; refer to CoA/Spec Sheet.
    • Research Use Note: For research use only.
  • General considerations for screening compounds (general guidance):

    • Compounds may modulate enzymes, receptors, ion channels, or protein–protein interactions; specific target(s) must be determined experimentally.
    • Hit compounds can show context-dependent activity, off-target effects, or assay interference; confirm activity across orthogonal assays and counter-screens.
    • ADME-relevant properties (permeability, metabolic stability, plasma protein binding) should be profiled if biological follow-up is planned.
  • Biochemical usage tips (general guidance):

    • Maintain consistent DMSO content across wells to avoid solvent-driven artifacts.
    • Evaluate colloidal aggregation using detergent controls and dynamic light scattering where feasible.
  • Disclaimer: No biological mechanism, pathway association, or target specificity is assigned to this item in the listing. Avoid inferring therapeutic relevance; this product is intended solely for laboratory research.

Buffer Applications

This item is not a buffer component. However, small-molecule stocks are commonly introduced into buffer systems for biochemical and cell-based assays.

  • Item-specific facts (from Product Data):

    • No buffer specifications are provided for this item.
  • Practical guidance (general, not item-specific):

    • Prepare concentrated stock in DMSO (e.g., 10–50 mM), then dilute into assay buffer (e.g., PBS, HEPES, Tris) to the desired final concentration.
    • Keep final DMSO ≤0.1–1.0% v/v depending on assay tolerance; match vehicle controls.
    • If precipitation occurs upon dilution, increase co-solvent fraction (e.g., to 2–5% DMSO) if biologically acceptable, or pre-dissolve with a miscible co-solvent (DMF, EtOH) before buffer addition.
    • For pH-sensitive compounds, use well-buffered media (HEPES pH 7.2–7.6 or appropriate pH range) and avoid extreme pH that may cause degradation.
  • Filtration and sterility (general guidance):

    • For cell assays, sterile-filter (0.22 µm) final working solutions if solubility allows.
  • Not applicable elements:

    • No defined buffering capacity, pKa set, or standard buffer recipes exist for this listing; refer to assay-specific SOPs.
Green Alternatives

In the absence of item-specific solvent/handling constraints, greener practice focuses on solvent selection, energy use, and waste minimization (general guidance).

  • Greener solvent choices for stocks and assays (general guidance):

    • Favor aqueous buffers with minimal co-solvent where feasible; limit DMSO to the lowest assay-compatible level (often ≤0.1–0.5% v/v).
    • Consider ethanol or propylene carbonate as alternatives for certain assays; evaluate biological compatibility carefully.
  • Process considerations:

    • Use miniaturized assay volumes (384/1536-well) to reduce solvent use and waste.
    • Implement plate maps that minimize repeats and concentrate confirmatory testing to reduce consumables.
  • Comparison (general guidance):

    • DMSO: excellent solvency, low volatility, widely compatible; environmental persistence is moderate; use sparingly.
    • Ethanol: renewable origins possible, rapidly biodegradable, but less solvating power and potential assay perturbation at >0.5% v/v.
    • Acetonitrile: high volatility and flammability; useful analytically but less green; capture vapors with proper ventilation and recover via solvent recycling when possible.
  • Waste and energy:

    • Consolidate organic wastes for solvent recycling; adopt cold-storage sparingly if stability at room temperature is confirmed (this item lists room temperature storage).
  • Item-specific green notes: No dedicated green profile is provided for this item; refer to SDS/CoA for any stabilizer or solvent information that may influence greener handling.

Pharmaceutical Uses

No pharmaceutical or excipient use is specified. This item is supplied strictly for research use only.

  • Item-specific facts (from Product Data):

    • Research Use Note: For research use only.
    • Pharmacopeial status (USP/EP/JP): Not specified for this item; refer to CoA/Spec Sheet.
  • General context (not item-specific):

    • Screening compounds may be used in discovery workflows (hit ID, SAR, mechanism studies) but are not intended for formulation or clinical use.
    • If transitioning a research hit toward development, extensive qualification is required (impurity profiling, polymorph assessment, residual solvent/water content, stability indicating methods) under appropriate quality systems.
  • Manufacturing/formulation notes (general guidance):

    • If used as an internal process control or analytical standard, document purity, reference spectra, and storage conditions.
    • Establish handling controls to prevent cross-contamination within drug product facilities; segregate research-only materials.
  • Disclaimer: No clinical, therapeutic, or diagnostic claims are made or implied for this product.

Physical Properties

Item-specific physical property data are not included in the listing.

  • Item-specific facts (from Product Data):

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • Storage Conditions: Room temperature (as supplied).
  • Properties typically reported for small molecules (literature/general guidance; not item-specific):

    • Melting point (solids) or boiling point (liquids) to assess purity and stability.
    • Solubility screening in DMSO, DMF, ethanol, acetonitrile, and aqueous buffers with co-solvent.
    • LogP/logD and pKa to anticipate permeability and ionization behavior.
    • Density and refractive index (for liquids) for handling and QC.
  • Practical characterization workflow (general guidance):

    • Start with a 10–50 mM stock in dry DMSO; inspect for complete dissolution by visual check and analytical HPLC.
    • If solubility is limited, test co-solvents (DMF, NMP, ethanol) or add surfactant (e.g., 0.01–0.05% Tween 80) to aqueous assay buffers.
    • Record exact concentration by UV-Vis (if chromophore present with known ε) or quantitative NMR against an internal standard.
  • Note: Specific numerical values for BP/MP, density, solubility, pKa, logP, and refractive index are not specified for this item; refer to CoA/Spec Sheet.

Quality and Grades

Quality and grade designations are not specified for this catalog entry.

  • Item-specific facts (from Product Data):

    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • What to expect for screening-library small molecules (general guidance):

    • Typical purity thresholds are ≥95% (HPLC/UPLC, UV or ELSD) for screening-grade materials; confirm on the CoA.
    • Identity confirmation by LC–MS (±0.5–5 ppm HRMS when available) and 1H NMR; some libraries include 13C NMR and elemental analysis.
    • Residual solvent and water contents may be reported by GC and KF, respectively; if critical for your use, request the latest CoA.
  • UV profile and stabilizers (general guidance):

    • HPLC/UPLC chromatograms at multiple wavelengths (e.g., 210/254/280 nm) are useful when planning analytical methods.
    • Stabilizers/antioxidants are generally not added to screening compounds; if any stabilizer is used, it will be declared on the spec. Not specified for this item; refer to CoA/Spec Sheet.
  • Batch-to-batch consistency:

    • For biological screening, verify lot-to-lot purity and identity before hit confirmation.
    • Store aliquoted to minimize freeze–thaw or moisture uptake; see Storage & Reconstitution.
Reaction and Applications

This product is categorized as a small-molecule library member intended for research screening rather than as a synthetic reagent.

  • Item-specific facts (from Product Data):

    • Category: Small molecules and compound libraries (screening context).
    • Manufacturer Applications: Not specified in the listing.
  • Research applications (general guidance):

    • Primary use in high-throughput screening (HTS), fragment or lead discovery, and target deconvolution workflows.
    • Suitable for phenotypic assays, biochemical inhibition/activation screens, and binding assays (e.g., thermal shift, SPR, MST), subject to assay compatibility.
    • Use in orthogonal assay panels to confirm activity and reduce interference risk (e.g., redox cycling, aggregation).
  • Practical considerations (general guidance):

    • Prepare mother plates at 10 mM (DMSO) and create daughter plates by serial dilution under low-humidity to limit DMSO evaporation.
    • Include DMSO-only controls at matching concentrations; monitor for assay artifacts (inner-filter effects, fluorescence interference).
    • Test for compound aggregation (e.g., with 0.01–0.05% nonionic detergent) and redox activity (e.g., Amplex Red counter-screens) when signals are ambiguous.
  • Note: This item is not positioned as a reagent for named organic reactions; if you intend to derivatize or use it synthetically, obtain the full structure and compatibility data from the CoA/Spec Sheet.

Reaction Conditions

No synthetic reaction usage is specified for this catalog entry. If the compound is to be used as a substrate or intermediate, consult the complete structural information first.

  • Item-specific facts (from Product Data):

    • No reaction or processing conditions are provided.
  • General guidance (not item-specific):

    • For solution preparation: dissolve in dry DMSO (10–50 mM), optionally warm (≤40–50°C) and sonicate to aid dissolution; avoid moisture-sensitive handling unless the CoA indicates sensitivity.
    • For assay incubation: typical exposure times vary from minutes to hours at ambient to physiological temperatures (25–37°C) depending on the assay design; confirm stability over the assay window.
    • Photostability: in the absence of data, minimize light exposure during preparation and storage as a conservative practice.
  • Expected yields, catalysts, and temperatures for chemical reactions are not applicable here due to lack of structural/functional group data.

  • Please refer to the CoA/Spec Sheet and SDS for any constraints (e.g., sensitivity to acid/base, oxidants, or air) that would influence handling.

Safety and Handling

Safety information specific to this item is not provided in the listing. Always consult the product SDS for authoritative guidance.

  • Item-specific facts (from Product Data):

    • GHS Classification, Signal Word, H-Statements, Pictograms: Not specified for this item; refer to SDS.
    • Storage: Room temperature (as supplied).
  • General laboratory precautions for small-molecule library compounds (general guidance):

    • Handle in a chemical fume hood; avoid inhalation of powders and contact with skin/eyes.
    • Wear appropriate PPE: lab coat, safety glasses, and chemical-resistant gloves (e.g., nitrile). Change gloves periodically.
    • Prevent dust generation; use antistatic measures when dispensing microgram–milligram quantities.
    • Avoid contact with strong oxidizers, strong acids/bases, and reducing agents unless compatibility is confirmed (general chemical reactivity guidance).
    • In case of spill: contain, collect with inert absorbent, and dispose according to institutional and regulatory requirements.
  • First-aid overview (general guidance):

    • Inhalation: move to fresh air, seek medical attention if symptoms persist.
    • Skin/eye contact: rinse with water for 15 minutes, remove contaminated clothing, seek medical advice.
    • Ingestion: rinse mouth, do not induce vomiting unless directed by medical personnel; seek medical attention.
  • Waste: Collect solid and liquid waste in labeled hazardous waste containers per local regulations. Defer to SDS for disposal codes and methods.

Solvent Selection

No item-specific solubility data are provided. The following is general guidance for small-molecule screening compounds.

  • Primary solvent for stocks (general guidance):

    • DMSO is the default due to broad solvating power and assay compatibility up to 0.1–1% v/v in many biochemical and cell assays.
  • Secondary/alternative solvents (general guidance):

    • DMF or NMP for highly apolar or crystalline compounds; subsequently dilute into aqueous buffers.
    • Acetonitrile or ethanol as co-solvents for LC compatibility or volatile removal.
    • Aqueous buffers (e.g., PBS, HEPES) with 0.1–20% DMSO or 1–10% ethanol, as permitted by the assay.
  • Practical workflow:

    • Start with 10–50 mM DMSO stock; if insoluble, warm gently (≤40–50°C) and sonicate; avoid prolonged heating.
    • Check clarity after dilution into assay buffer; if precipitation occurs, increase co-solvent fraction or reduce final concentration.
    • Filter 0.22 µm before high-precision assays to remove particulates.
  • Comparison notes (general guidance):

    • DMSO vs DMF: DMSO is more biocompatible; DMF may extract plastics and is less preferred for cell assays.
    • DMSO vs ethanol: ethanol is more volatile and can affect membrane integrity; limit final ethanol below typical cytotoxic thresholds (often ≤0.5% v/v, assay-dependent).
Storage and Reconstitution

Item-specific storage is provided; reconstitution details are not specified.

  • Item-specific facts (from Product Data):

    • Storage Conditions: Room temperature.
    • Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
  • General storage guidance for small molecules (not item-specific):

    • Store tightly sealed, dry, and protected from excessive heat and humidity. Consider desiccation and amber containment to minimize hydrolysis/photolysis when structure is unknown.
    • For long-term use, prepare single-use aliquots of DMSO stocks (e.g., 10–50 mM) and store at −20°C to −80°C to minimize freeze–thaw; validate stability experimentally.
    • Allow frozen DMSO stocks to thaw at room temperature; vortex and briefly centrifuge to collect condensate; inspect for precipitation or color change before use.
  • Reconstitution (general guidance):

    • Dissolve the material in anhydrous DMSO to prepare a concentrated stock; confirm concentration by mass and volume or analytical assay (UV-Vis if chromophore known, or qNMR).
    • Filter (0.22 µm PTFE) if particulate is present and solubility permits.
  • Note: Any specific stabilizers, hydrates/solvates, or reconstitution requirements are not specified for this item; refer to CoA/Spec Sheet and SDS for definitive instructions.

Structure and Identity

Brief overview: This listing corresponds to a small-molecule screening compound from a chemical library. Item-specific structural identifiers are largely not provided in the product data.

  • Item-specific facts (from Product Data):

    • CAS: 796888-12-5
    • CID: 2951910
    • InChIKey: "78702" (as provided; note: this is an atypical/non-standard InChIKey format)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general guidance):

    • Without a provided SMILES or structure diagram, ring systems, functional groups, and stereochemistry cannot be enumerated for this specific item.
  • How to verify identity (general practice):

    • Cross-check the CAS and CID in authoritative databases (e.g., CAS Registry, PubChem) to retrieve the canonical SMILES, InChI, and 2D/3D structures (literature/general guidance).
    • Confirm identity by LC–MS and 1H/13C NMR against the vendor CoA/Spec Sheet and reference spectra (general guidance).
  • 2D structure description: Not available due to missing structural data in the listing. Please consult the CoA, SDS, or Spec Sheet for the definitive structural depiction.

Synthetic Utility

This product is positioned as a screening compound rather than a synthetic building block; therefore, routine use as a reagent is not anticipated.

  • Item-specific facts (from Product Data):

    • Structure and functional groups: Not specified for this item; refer to CoA/Spec Sheet.
  • General considerations if derivatization is contemplated (general guidance):

    • Obtain the full structure (SMILES/InChI) and identify functional handles (e.g., aryl halides, amines, acids) before planning transformations.
    • Verify stability to common conditions (acid/base, oxidative, reductive, thermal) and assess protecting-group needs.
    • For SAR expansion, retain the core scaffold while varying substituents via cross-coupling, amide coupling, or heterocycle substitutions as appropriate—contingent on the actual functional groups present.
  • Analytical control (general guidance):

    • Employ LC–MS and NMR to track reaction progress and purity; use orthogonal methods (HRMS, HPLC-ELSD) for non-UV-active products.
  • Note: Without a declared structure, specific reaction pathways, named reactions, or reactivity predictions cannot be provided for this item.

Target Specificity

No target or specificity information is provided for this item.

  • Item-specific facts (from Product Data):

    • Target, pathway, species selectivity, and mechanism: Not specified for this item; refer to CoA/Spec Sheet.
  • General guidance for researchers:

    • Use orthogonal assays (biochemical and cellular) to define on-target activity.
    • Profile off-target liabilities via counterscreens (e.g., frequent hitters, PAINS, colloidal aggregation tests) and broad panels if advancing as a probe.
    • Determine binding via biophysical methods (SPR, ITC, DSF) and confirm functional outcome in mechanistic assays.
  • Note: Any claims of target specificity must be derived from your experimental data or authoritative references; none are assigned in this listing.

Preguntas frecuentes

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 796888-12-5, the molecular formula is C20H22N4O2, and the molecular weight is 350.41 g/mol. InChIKey FBWZAFQEOKNGQL-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.